A comparison of the cardiometabolic profile of black South Africans with suspected non-alcoholic fatty liver disease (NAFLD) and excessive alcohol use

Alcohol

Volumn 49, Issue 2, 2015, Pages 165-172

  Zatu, Mandlenkosi Caswell ^a,b   van Rooyen, Johannes Marthinus ^a   Loots, Du Toit ^a   Greeff, Minrie ^a   Schutte, Aletta Elisabeth ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

Author keywords

Blood pressure; Cardiovascular disease; High density lipoprotein cholesterol; Hypertension; Low socio economic status; Non alcoholic steatohepatitis

Indexed keywords

CARBOHYDRATE DEFICIENT TRANSFERRIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; BLACK PERSON; BODY MASS; CARDIOMETABOLIC RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; RISK ASSESSMENT; SELF REPORT; SEX DIFFERENCE; SMOKING; SOUTH AFRICAN; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; COHORT ANALYSIS; DRINKING BEHAVIOR; ETHNOLOGY; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; SOUTH AFRICA;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALCOHOL DRINKING; BLOOD PRESSURE; CHOLESTEROL, HDL; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROSPECTIVE STUDIES; SOUTH AFRICA;

EID: 84924937916     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2014.11.002     Document Type: Article

References (61)

1. Akinkuolie A.O., Paynter N.P., Padmanabhan L., Mora S. High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease. Circulation: Cardiovascular Quality and Outcomes 2014, 7:55-63.
2. Andersen K.K., Olsen T.S. The obesity paradox in stroke: lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients. International Journal of Stroke 2013, (Epub ahead of print). 10.1111/ijs.12016.
3. Ariesen M.J., Claus S.P., Rinkel G.J., Algra A. Risk factors for intracerebral haemorrhage in the general population: a systematic review. Stroke 2003, 34:2060-2065.
4. Bagheri B., Shokrzadeh M., Mokhberi V., Azizi S., Khalilian A., Akbari N., et al. Association between serum iron and the severity of coronary artery disease. International Cardiovascular Research Journal 2013, 7:95-98.
5. Bayard M., Holt J., Boroughs E. Non-alcoholic fatty liver disease. American Family Physician 2006, 73:1961-1968.
6. Bhatia L.S., Curzen N.P., Calder P.C., Byrne C.D. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?. European Heart Journal 2012, 33:1190-1200.
7. Bots M.L., Elwood P.C., Nikitin Y., Salonen J.T., Freire de Concalves A., Inzitari D., et al. Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. Journal of Epidemiology and Community Health 2002, 56:19-24.
8. Breslow R.A., Smothers B.A. Drinking patterns and body mass index in never smokers. National health interview survey, 1997-2001. American Journal of Epidemiology 2005, 161:368-376.
9. Chiolero A., Faeh D., Paccaud F., Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. American Journal of Clinical Nutrition 2008, 87:801-809.
10. DeBoer M.D., Dong L., Gurka M.J. Racial/ethnic and gender differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of NHANES 1999-2006. Metabolism 2012, 61:554-561.
11. Elkind M.S.V., Sciacca R., Boden-Albala B., Rundek T., Paik M.C., Sacco R.L. Moderate alcohol consumption reduces risk of ischemic stroke. The Northern Manhattan Study. Stroke 2006, 37:13-19.
12. Fujita M., Hata A. Sex and age differences in the effect of obesity onincidence of hypertension in the Japanese population: a large historicalcohort study. Journal of the American Society of Hypertension 2013, 8:64-70.
13. Gaggini M., Morelli M., Buzzigoli E., DeFronzo R.A., Bugianesi E., Gastaldelli G. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013, 5:1544-1560.
14. Hall P., Cash J. What is the real function of the liver 'function' tests?. The Ulster Medical Journal 2012, 81:30-36.
15. Hilawe E.H., Yatsuya H., Kawaguchi L., Aoyama A. Prevalence of diabetes mellitus, impaired fasting glycemia and impaired glucose tolerance in sub-Saharan Africa: a systematic review and meta analysis. Bulletin of the World Health Organization 2013, 91:671D-682D.
16. Houschyar K.S., Lüdtke R., Dobos G.J., Kalus U., Broecker-Preuss M., Rampp T., et al. Effects of phlebotomy-induced reduction of body iron stores onmetabolic syndrome: results from a randomized clinical trial. BMC Medicine 2012, 10:54.
17. Huang Y.Y., Gusdon A.M., Qu S. Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies. Lipids in Health and Diseases 2013, 12:171.
18. Hwu C., Lin K. Uric acid and the development of hypertension. Medical Science Monitor 2010, 16:RA224-230.
19. Junghanns K., Graf I., Pflüger J., Wetterling G., Ziems C., Ehrenthal D., et al. Urinary ethyl glucuronide (EtG) and ethyl sulphate (EtS) assessment. Valuable tools to improve verification of absention in alcohol-dependent patients during in-patient treatment and at follow-ups. Addiction 2009, 104:921-926.
20. Kolapo K.O., Vento S. Stroke: a realistic approach to a growing problem in sub-Saharan Africa is urgently needed. Tropical Medicine & International Health 2011, 16:707-710.
21. Koppes L.L., Twisk J.W., Van Mechelen W., Snel J., Kemper H.C. Cross-sectional and longitudinal relationships between alcohol consumption and lipids, blood pressure and body weight indices. Journal of Studies on Alcohol 2005, 66:713-721.
22. Kruger F.C., Daniels C., Kidd M., Swart G., Brundyn K., van Rensburg C., et al. Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: a descriptive analysis. South African Medical Journal 2010, 100:168-171.
23. Lukasiewicz E., Mennen L.I., Bertrais S., Arnault N., Preziosi P., Galan P., et al. Alcohol intake in relation to body mass index and waist-to-hip ratio: the importance of type of alcohol beverage. Public Health Nutrition 2005, 8:315-320.
24. Marfel-Jones M., Olds T., Stewart A.D., Cartel J.E.L. International standards for anthropometric assessment 2006, International Society for the advancement of Kinanthropometry, Potchefstroom, South Africa.
25. Marques-Vidal P., Bochud M., Paccaud F., Waterworth D., Bergmann S., Preisig M. No interaction between alcohol consumption and HDL-related genes on HDL cholesterol levels. Atherosclerosis 2010, 211:551-557.
26. Mason J.E., Starke R.D., Van Kirk J.E. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Preventive Cardiology 2010, 13:36-41.
27. Matsha T.E., Macharia M., Yako Y.Y., Erasmus R.T., Hassan M.S., Kengne A.P. Gamma-glutamyltransferase, insulin resistance and cardiometabolic risk profile in a middle-aged African population. European Journal of Preventive Cardiology 2014, 21:1541-1548. (Epub ahead of print).
28. Muñoz-Bravo C., Gutiérrez-Bedmar M., Gómez-Aracena J., García-Rodríguez A., Navajas J.F. Iron: protector or risk factor for cardiovascular disease? Still controversial. Nutrients 2013, 5:2384-2404.
29. Nguyen G.C., Thuluvath P.J. Racial disparity in liver disease: biological, cultural, or socioeconomic factors. Hepatology 2008, 47:1058-1066.
30. Ong J.P., Elariny H., Collantes R., Younoszai A., Chandhoke V., Reines H.D., et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obesity Surgery 2005, 15:310-315.
31. Onyekwere C.A., Ogbera A.O., Balogun B.O. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community. Annals of Hepatology 2011, 10:119-124.
32. Opie L.H., Seedat Y.K. Hypertension in sub-Saharan African populations. Circulation 2005, 112:3562-3568.
33. Palmer I.M., Schutte A.E., Huisman H.W. Uric acid and the cardiovascular profile of African and Caucasian men. Journal of Human Hypertension 2010, 24:639-645.
34. Puoane T., Steyn K., Bradshaw D., Laubscher R., Fourie J., Lambert V., et al. Obesity in South Africa: the South African demographic and health survey. Obesity Research 2002, 10:1038-1048.
35. Puukka K., Hietala J., Koivisto H., Anttila P., Bloigu R., Niemelä O. Additive effects of moderate drinking and obesity on serum gamma-glutamyltransferase activity. The American Journal of Clinical Nutrition 2006, 83:1351-1354.
36. Rajapurkar M.M., Shah S.V., Lele S.S., Hegde U.N., Lensing S.Y., Gohel K., et al. Association of catalytic iron with cardiovascular disease. American Journal of Cardiology 2012, 109:438-442.
37. Scaglioni F., Ciccia S., Marino M., Bedogni G., Bellentani S. ASH and NASH. Digestive Diseases 2011, 29:202-210.
38. Schroder H., Morales-Molina J.A., Bermejo S., Barral D., Mandoli E.S., Grau M., et al. Relationship of abdominal obesity with alcohol consumption at population scale. Euopean Journal of Nutrition 2007, 46:369-376.
39. Schutte A.E., Huisman H.W., Van Rooyen J.M., Schutte R., Malan L., Reimann M., et al. Should obesity be blamed for the high prevalence rates of hypertension in black South African women?. Journal of Human Hypertension 2008, 22:528-536.
40. Schutte A.E., Schutte R., Huisman H.W., van Rooyen J.M., Fourie C.M., Malan N.T., et al. Are behavioural risk factors to be blamed for the conversion from optimal blood pressure to hypertensive status in Black South Africans? A 5-year prospective study. International Journal of Epidemiology 2012, 41:1114-1123.
41. Setlalentoa B.M.P., Pisa P.T., Thekisho G.N., Ryke E.H., Loots Du T. The social aspects of alcohol misuse/abuse in South Africa. South African Journal of Clinical Nutrition 2010, 23:S11-S15.
42. Shisana O., Labadarios D., Rehle T., Simbayi L., Zuma K., Dhansay A., et al. South African National Health and Nutrition Examination Survey (SANHANES-1) 2013, HSRC Press, Cape Town.
43. Sliwa K., Wilkinson D., Hansen C., Ntyintyane L., Tibazarwa K., Becker A., et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008, 371:915-922.
44. Stewart S., Libhaber E., Carrington M., Damasceno A., Abbasi H., Hansen C., et al. The clinical consequences and challenges of hypertension in urban-dwelling black Africans: Insights from the Heart of Soweto Study. International Journal of Cardiology 2011, 146:22-27.
45. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with non-alcoholic fatty liver disease. The New England Journal of Medicine 2010, 363:1341-1350.
46. Teo K., Chow C.K., Vaz M., Rangarajan S., Yusuf S. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic non-communicable diseases in low-, middle-, and high-income countries. American Heart Journal 2009, 58:1-7. PURE Investigators Writing Group.
47. Tikhonoff V., Zhang H., Richart T., Staessen J.A. Blood pressure as a prognostic factor after acute stroke. The Lancet. Neurology 2009, 10:938-948.
48. Torrente M.P., Freeman W.M., Vrana K.E. Protein biomarkers of alcohol abuse. Expert Review of Proteomics 2012, 9:425-436.
49. Tsai J., Ford E.S., Li C., Zhao G. Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults. Addictive Behaviors 2012, 37:78-84.
50. Tsushima Y., Nishizawa H., Tochino Y., Nakatsuji H., Sekimoto R., Nagao H., et al. Uric acid secretion from adipose tissue and its increase in obesity. The Journal of Biological Chemistry 2013, 288:27138-27149.
51. Tsuzaki K., Kotani K., Fujiwara S., Sano Y., Sakane N. High-density lipoprotein size distribution can differ between subjects with alcoholic and non-alcoholic fatty liver disease. Clinical Laboratory 2014, 60:319-322.
52. Tuei V.C., Maiyoh G.K., Ha C.K. Type 2 diabetes mellitus and obesity in sub-Saharan Africa. Diabetes/Metabolism Research and Reviews 2010, 26:433-445.
53. Twagirumukiza M., De Bacquerb D., Kips J.G., de Backer G., Vander Stichele R., Van Bortel L.M. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. Journal of Hypertension 2011, 29:1243-1252.
54. Van Rooyen J.M., Kruger H.S., Huisman H.W., Wissing M.P., Margetts B.M., Venter C.S., et al. An epidemiological study of hypertension and its determinants in a population in transition: the THUSA study. Journal of Human Hypertension 2000, 14:779-787.
55. Van der Merwe M.T., Pepper M.S. Obesity in South Africa. Obesity Reviews 2006, 7:315-322.
56. Van der Steeg W.A., Holme I., Boekholdt S.M., Larsen M.L., Lindahl C., Stroes E.S.G., et al. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. Journal of the American College of Cardiology 2008, 51:634-642.
57. Vernon G., Baranova A., Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics 2011, 34:274-285.
58. Viel G., Boscolo-Berto R., Cecchetto G., Fais P., Nalesso A. Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis. International Journal of Molecular Sciences 2012, 13:14788-14812.
59. Wakabayashi I. Relationships among alcohol drinking, blood pressure andserum cholesterol in healthy young women. Clinica Chimica Acta 2008, 388:192-195.
60. Wang X., Li S., Bai Y., Fan X., Sun K., Wang J., et al. Inverse association of plasma level of high-density lipoprotein cholesterol with intracerebral haemorrhage. Journal of Lipid Research 2011, 52:1747-1754.
61. Yeomans M.R. Alcohol, appetite and energy balance: is alcohol intake a risk factor for obesity?. Physiology & Behavior 2010, 100:82-89.